Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to Fluoroquinolones and linezolid

被引:100
作者
Escribano, I.
Rodriguez, C.
Llorca, B.
Garcia-Pachon, E.
Ruiz, M.
Royo, G.
机构
[1] Hosp Gen Univ Elche, Microbiol Sect, ES-03203 Elche, Spain
[2] Univ Miguel Hernandez, Hosp Gen Univ Elche, Sect Pneumol, ES-03203 Elche, Spain
关键词
Mycobacterium tuberculosis; fluoroquinolones; efflux pumps; linezolid; drug resistance; IN-VITRO ACTIVITY; QUINOLONE RESISTANCE; SUSCEPTIBILITY; LEVOFLOXACIN; OFLOXACIN; MUTANTS; CLONING; GYRASE;
D O I
10.1159/000109769
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Our aim was to study the influence of efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid. Methods: We studied the mutations in gyrA and gyrB genes and the influence of efflux pump systems with 2 inhibitors ( reserpine and MC 207.110). Results: The effect of the active efflux system on the decrease in sensitivity to ciprofloxacin, moxifloxacin, levofloxacin, ofloxacin, gatifloxacin and linezolid was studied by investigating the variation in the in vitro activity of these compounds when assayed in association with reserpine and MC 207.110. These inhibitors exhibit activity both in strains that are resistant and in strains that are susceptible to these antibiotics. However, they are seen to be most active in resistant strains, since the minimum inhibitory concentration of the antibiotics studied in these strains was reduced between 2- and 6- fold. Conclusions: Therefore, these mechanisms are involved in the resistance to both compounds. It would be of interest to carry out further studies to determine to what extent these active efflux systems influence resistance to the different groups of drugs used in the treatment of tuberculosis, with a view to the possibility of using the inhibitors of these systems in future therapeutic applications.
引用
收藏
页码:397 / 401
页数:5
相关论文
共 50 条
  • [41] Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistant Mycobacterium tuberculosis through Efflux
    Louw, Gail E.
    Warren, Robin M.
    Gey van Pittius, Nicolaas C.
    Leon, Rosalba
    Jimenez, Adelina
    Hernandez-Pando, Rogelio
    McEvoy, Christopher R. E.
    Grobbelaar, Melanie
    Murray, Megan
    van Helden, Paul D.
    Victor, Thomas C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (02) : 269 - 276
  • [42] Isoniazid and verapamil modulatory activity and efflux pump gene expression in Mycobacterium tuberculosis
    de Souza, J. V. P.
    Murase, L. S.
    Caleffi-Ferracioli, K. R.
    Palomo, C. T.
    Scodro, R. B. de Lima
    Siqueira, V. L. D.
    Pavan, F. R.
    Cardoso, R. F.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2020, 24 (06) : 591 - +
  • [43] Structures of the Mycobacterium tuberculosis efflux pump EfpA reveal the mechanisms of transport and inhibition
    Wang, Shuhui
    Wang, Kun
    Song, Kangkang
    Lai, Zon Weng
    Li, Pengfei
    Li, Dongying
    Sun, Yajie
    Mei, Ye
    Xu, Chen
    Liao, Maofu
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [44] Critical discussion on drug efflux in Mycobacterium tuberculosis
    Remm, Sille
    Earp, Jennifer C.
    Dick, Thomas
    Dartois, Veronique
    Seeger, Markus A.
    FEMS MICROBIOLOGY REVIEWS, 2022, 46 (01)
  • [45] Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran
    Sayadi, Mahdieh
    Zare, Hosna
    Jamedar, Saeed Amel
    Hashemy, Seyed Isaac
    Meshkat, Zahra
    Soleimanpour, Saman
    Hoffner, Sven
    Ghazvini, Kiarash
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [46] Evaluation of quinolone resistance-determining region mutations and efflux pump expression in Neisseria meningitidis resistant to fluoroquinolones
    Castanheira, Mariana
    Deshpande, Lalitagauri M.
    Jones, Ronald N.
    Farrell, David J.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2012, 72 (03) : 263 - 266
  • [47] Morphological changes and differentially expressed efflux pump genes in Mycobacterium tuberculosis exposed to a rifampicin and verapamil combination
    Caleffi-Ferracioli, Katiany R.
    Amaral, Renata Claro R.
    Demitto, Fernanda O.
    Maltempe, Flaviane G.
    Canezin, Pedro Henrique
    Scodro, Regiane B. L.
    Nakamura, Celso V.
    Leite, Clarice Queico F.
    Siqueira, Vera Lucia D.
    Cardoso, Rosilene F.
    TUBERCULOSIS, 2016, 97 : 65 - 72
  • [48] Involvement of Efflux Pumps in the Resistance to Peptidoglycan Synthesis Inhibitors in Mycobacterium tuberculosis
    Dinesh, Neela
    Sharma, Sreevalli
    Balganesh, Meenakshi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (04) : 1941 - 1943
  • [49] Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance
    Devasia, Rose A.
    Blackman, Amondrea
    May, Carolyn
    Eden, Svetlana
    Smith, Teresa
    Hooper, Nancy
    Maruri, Fernanda
    Stratton, Charles
    Shintani, Ayumi
    Sterling, Timothy R.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1173 - 1178
  • [50] Fluoroquinolones for the treatment of latent Mycobacterium tuberculosis infection in liver transplantation
    Jose Tiago Silva
    Rafael San-Juan
    Mario Fernández-Ruiz
    José María Aguado
    World Journal of Gastroenterology, 2019, (26) : 3291 - 3298